# Ahmed Kaldun Nossuli M.D., Principal Investigator – FDA Inspection, Sep 18, 2020

Source: https://www.keypedia.com/records/fda_inspections/ahmed-kaldun-nossuli-md-principal-investigator/b2b9f874-8b05-437f-aeed-f345ce116ac9
Source feed: FDA_Inspections

> FDA inspection 1129601 of Ahmed Kaldun Nossuli M.D., Principal Investigator, September 18, 2020. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1129601
- Company Name: Ahmed Kaldun Nossuli M.D., Principal Investigator
- Inspection Date: 2020-09-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1062066 - 2018-08-14](https://www.keypedia.com/records/fda_inspections/ahmed-kaldun-nossuli-md-principal-investigator/2529cb2a-c6b2-41a1-a9c9-553786e90a31)
- FDA Inspection 838900 - 2013-06-10

Company: https://www.keypedia.com/companies/ahmed-kaldun-nossuli-md-principal-investigator/abed3af2-8f50-4693-99cf-ca14db6168d8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
